ALCAR Share Price Performance
€0.099
-0.71 (-87.72%)
Price €0.099
Share Pricen/a
No recently updated narratives available.
Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.